Calcinosis Prevalence in Autoimmune Connective Tissue Diseases-A Retrospective Study.
Lili RóbertKrisztián NémethMárta MarschalkóPéter HollóBernadett HidvégiPublished in: Journal of clinical medicine (2024)
Background/Objectives : Calcinosis cutis is the deposition of insoluble calcium salts, which may cause inflammation, ulceration, pain, and restricted joint mobility. It rarely develops in damaged tissues (dystrophic subtype), most frequently in autoimmune connective tissue diseases (CTDs), but there is very limited data on the prevalence. Also, therapy remains an unsolved issue. In this study, we aimed to collect data on the prevalence of calcinosis in CTD patients to highlight that it is a considerable problem. Methods : A retrospective study was conducted in our department to assess the epidemiology of dystrophic calcinosis in CTDs between January 2003 and January 2024. Results : A total of 839 CTD patients were identified, of whom 56 had calcinosis (6.67%). The mean age of the calcinosis patients at diagnosis of underlying CTD was 41.16 ± 19.47 years. The mean time interval from the onset of calcinosis was 5.96 ± 8.62 years. Systemic sclerosis was the most common CTD complicated by calcinosis (n = 22). Conclusions : Our results are comparable to those reported previously in the literature. Although calcinosis is rare in the overall population, it is a present and unsolved problem in CTD patients. Therefore, further studies are needed on the factors involved in the development and progression of calcinosis as well as its treatment.
Keyphrases
- end stage renal disease
- systemic sclerosis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- risk factors
- multiple sclerosis
- stem cells
- chronic pain
- gene expression
- patient reported outcomes
- spinal cord
- bone marrow
- mesenchymal stem cells
- artificial intelligence
- idiopathic pulmonary fibrosis